1. Chen KH, Lin CY, Su SB, Chen KT. Leprosy: A review of epidemiology, clinical diagnosis, and management. Journal of Tropical Medicine. 2022 Jul 4;2022.
2. Schoenmakers A, Mieras L, Budiawan T, van Brakel WH. The state of affairs in post-exposure leprosy prevention: a descriptive meta-analysis on immuno-and Chemo-Prophylaxis. Research and reports in tropical medicine. 2020 Oct 15:97-117.
3. Ignotti E, Steinmann P. Perspectives for leprosy control and elimination. Cadernos de Saúde Pública. 2020 Jul 3;36.
4. Richardus JH, Tiwari A, Barth-Jaeggi T, Arif MA, Banstola NL, Baskota R, Blaney D, Blok DJ, Bonenberger M, Budiawan T, Cavaliero A. Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme. The Lancet Global Health. 2021 Jan 1;9(1):e81-90.
5. van Hooij A, van den Eeden SJ, Khatun M, Soren S, Franken KL, Roy JC, Alam K, Chowdhury AS, Richardus JH, Geluk A. BCG-induced immunity profiles in household contacts of leprosy patients differentiate between protection and disease. Vaccine. 2021 Dec 8;39(50):7230-7.
6. World Health Organization. BCG vaccine: WHO position paper, February 2018–recommendations. Vaccine. 2018 Jun 7;36(24):3408-10.
7. Coppola M, van den Eeden SJ, Robbins N, Wilson L, Franken KL, Adams LB, Gillis TP, Ottenhoff TH, Geluk A. Vaccines for leprosy and tuberculosis: opportunities for shared research, development, and application. Frontiers in Immunology. 2018 Feb 26;9:308.
8. Ali L. Leprosy vaccines–a voyage unfinished. Journal of Skin and Sexually Transmitted Diseases. 2021 Apr 6;3(1):40-5.
Facebook 
Masuk dengan Email
